
Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination
J. Virol. Kong et al.
83: 2201
Supplemental material
Files in this Data Supplement:
- Supplemental file 1
-
Legends to Fig. S1 to S6
MS Word document, 35K.
- Supplemental file 2
-
Fig. S1 (Amino acid sequences of gp160 and mutant mosaics and best natural sequences.)
Zipped PDF file, 36K.
- Supplemental file 3
-
Fig. S2 (gp160ΔCFI mos 2 and mos 3 mosaics elicited more breadth of CD8 T-cell responses than gp160ΔCFI single mosaic, the two gp160ΔCFI natural strains sets, and gp145ΔCFI clades A, B, and C.)
Zipped PDF file, 323K.
- Supplemental file 4
-
Fig. S3 (gp160ΔVΔCFI mos 3 mosaics elicited similar breadth of CD8+ T-cell responses as gp160ΔCFI mos 3 mosaics but less than gp160 mos 3 mosaics.)
Zipped PDF file, 300K.
- Supplemental file 5
-
Fig. S4 (gp145ΔCFI mosaics showed minimal CD8+ T-cell responses to PTE peptide pool.)
Zipped PDF file, 300K.
- Supplemental file 6
-
Fig. S5 (gp160ΔV mosaics elicit fewer CD8+ T-cell responses than gp160 mosaics.)
Zipped PDF file, 252K.
- Supplemental file 7
-
Fig. S6 (Matched 9-mers by pool for vaccine candidates.)
Zipped PDF file, 160K.
- Supplemental file 8
-
Table S1 (The number of plates for each combination of vaccine and modification.)
Table S2 (Experimental design of different antigens analyzed in this study.)
Table S3 (Match counts between 9-mers found in vaccines (gp160 unmodified) and PTE peptide pools.)
Zipped MS Word document, 10K.